Sort
15,440 grants matching “organoids”
Microbiome-triggered reprogramming and mutation of colon epithelial cells leading to tumor stem-like cells
$421,648Mark M Huycke · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · CA
Role of Aryl Hydrocarbon Receptor in Microbiota-Colon Stem Cell Interactions
$421,647Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2019 · ES
Synthetic microfluidic synthesis of spinal cord tissues from human pluripotent stem cells
$421,635Jianping Fu · University Of Michigan At Ann Arbor · R21 · FY2019 · NS
Engineering Oral Tumor Microcirculation: Blood and lymphatic capillary network-enabled Human Oral Tumor Microenvironment Chips for Preclinical Research
$421,625Abhishek Jain · Texas Engineering Experiment Station · R21 · FY2025 · DE
MECHANISMS OF CHIEF CELL DEDIFFERENTIATION
$421,498Jason C Mills · Baylor College Of Medicine · R01 · FY2023 · DK
NIAAA/COGA Sharing Repository Core
$421,411Jay Arnold Tischfield · Suny Downstate Medical Center · U10 · FY2020 · AA
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
$421,219Ya-Wen Chen · University Of Southern California · R56 · FY2021 · HL
Cilia Assembly and Transport in Photoreceptor Cells
$421,194Brian D Perkins · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · EY
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
$421,180Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2021 · CA
Role of PD2/Paf1 in Pancreatic Acinar to Ductal Metaplasia
$421,180Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2020 · CA
Use of kidney organoids to investigate developmental programs and the effects of fetal exposures
$421,067Lori L O'Brien · Univ Of North Carolina Chapel Hill · R21 · FY2024 · HD
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
$420,941Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
RB tumor suppressor as a therapeutic target in ER-positive breast cancer
$420,941Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$420,922Alexander Y Nikitin · Cornell University · R01 · FY2023 · CA
Cancer-prone cell states of the fallopian tubal epithelium
$420,922Alexander Y Nikitin · Cornell University · R01 · FY2022 · CA
Targeted Identification of IBD Risk Gene Variant Impact on Immune-Epithelial Crosstalk and Intestinal Barrier Function
$420,894Declan McCole · University Of California Riverside · R01 · FY2025 · DK
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2021 · CA
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2019 · CA
Hormone signaling and translation control in advanced prostate cancer
$420,691Andrew Caleb Hsieh · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
iPSC Modeling of AD Using Progerin
$420,625Sally Temple · Regenerative Research Foundation · R01 · FY2017 · AG
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
$420,472Theresa Torres Pizarro · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · DK
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
$420,472Theresa Torres Pizarro · Case Western Reserve University · R01 · FY2023 · DK
The pathogenic roles of GSDMD-dependent gut epithelium extracellular vesicles in IBD
$420,472Theresa Torres Pizarro · Case Western Reserve University · R01 · FY2022 · DK
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
$420,442Bang H Hoang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Gene Therapy for Xeroderma Pigmentosum - Cockayne Syndrome.
$420,393Christina A. Pacak · University Of Minnesota · R61 · FY2025 · NS